Linkster engineers delivery-first medicines in oncology. Our proprietary VHH platform (Sybody®) and world's first in vivo HT-discovery engine (Flycode®) de-risk complex targets to generate precision ADCs and multispecifics at the earliest stages.
Cooperation possibilities
We invite partners to co-develop delivery-optimized ADCs, AOCs, and multispecifics. Our unique in vivo HT-platform navigates complex delivery challenges and builds precision assets across oncology, CNS, and beyond.
- http://www.linkstertx.com/
- Send an email
- Iwan Zimmermann, PhD
